MiNK Therapeutics, Inc. Other Non-Current Liabilities
MiNK Therapeutics, Inc. (INKT) had Other Non-Current Liabilities of $0 as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OtherLiabilitiesNoncurrent · last filed 2025-03-18
- 2024-12-31: Other Liabilities, Noncurrent $0.00.
- 2024-09-30: Other Liabilities, Noncurrent $2.94K.
- 2024-06-30: Other Liabilities, Noncurrent $23.28K.
- 2024-03-31: Other Liabilities, Noncurrent $31.60K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-18 |
| 2024-09-30 | $2.94K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $23.28K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $31.60K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $48.07K 10-K · filed 2025-03-18 |
| 2023-09-30 | $63.98K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $79.34K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $94.18K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $108.50K 10-K · filed 2024-03-21 |
| 2022-09-30 | $58.28K 10-Q · filed 2022-11-03 |
| 2021-09-30 | $27.54K 10-Q · filed 2021-11-29 |
| 2020-12-31 | $383.06K 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |